Regional News Archives - Page 74 of 190 - Journal for Clinical Studies

Current Edition

Regional News

JPM 2022: Vertex’s Trikafta holds the line as company lays groundwork for gene editing launch

Vertex Pharmaceuticals is well known for its slew of cystic fibrosis medications, and newcomer Trikafta is pulling its weight. Over the course of 2021, the med clinch...

11 January 2022 Regional News company | fibrosis

Continue Reading →

Regional News

ASH: Astellas looks for silver linings in failed Xospata combo trial

Eying growth in oncology, Astellas has suffered an R&D setback for acute myeloid leukemia drug Xospata (gilteritinib). The med flunked a combo trial with Bristol ...

15 December 2021 Regional News acute myeloid leukemia | Astellas

Continue Reading →

Regional News

Bayer targets 100% green packaging for consumer health brands by 2030 as part of €100 million sustainability plan

Eying growth in oncology, Astellas has suffered an R&D setback for acute myeloid leukemia drug Xospata (gilteritinib). The med flunked a combo trial with Bristol ...

15 December 2021 Regional News acute myeloid leukemia | Astellas

Continue Reading →

Regional News

ASH: Roche’s Polivy set to unlock $2B market in newly diagnosed lymphoma with practice-changing data

The guessing is over. Roche has detailed new Polivy data that could change nearly two decades of treatment standards in newly diagnosed lymphoma—while opening up a bl...

15 December 2021 Regional News antibody drug conjugates | ASH 2021

Continue Reading →

Regional News

ASH: Novartis thinks it knows why Kymriah failed in earlier lymphoma but shifts focus to next-gen CAR-T meds

Kymriah’s shocking failure in earlier lymphoma treatment has raised doubts about the Novartis drug’s potency in light of impressive victories from rival CAR-Ts by Gil...

15 December 2021 Regional News ASH 2021 | Breyanzi

Continue Reading →

Regional News

CSL to buy Vifor for $11.7B in biopharma’s largest M&A deal this year

In a move to diversify its business, Australian biopharma CSL has agreed to acquire Vifor Pharma for $11.7 billion. The deal would give CSL—heavily dependent on vacci...

15 December 2021 Regional News a CSL Behring | Fresenius

Continue Reading →

Regional News

AstraZeneca and other lung cancer specialists join together to emphasize early screenings

If there is one strong message Camille Hertzka, AstraZeneca vice president and head of oncology, U.S. medical, wants people to take away from lung cancer awareness su...

15 December 2021 Regional News AstraZeneca | Guardant Health

Continue Reading →

Regional News

CanSino taps Aerogen for development, commercial supply of inhaled COVID-19 vaccine hopeful

After months of collaborative work in the lab, China's CanSino Biologics and Irish drug delivery specialist Aerogen are taking their inhaled COVID-19 vaccine pact to ...

15 December 2021 Regional News Aerogen | coronavirus

Continue Reading →

Regional News

Shkreli’s former company Vyera settles for $40M in antitrust case, but ‘pharma bro’ still faces his own trials

A fraud conviction and seven-year prison sentence haven’t spared “Pharma Bro” and Wu-Tang Clan enthusiast Martin Shkreli from a federal antitrust lawsuit tied to his ...

13 December 2021 Regional News antitrust | Daraprim

Continue Reading →

Regional News

For pharmas dealing with HCPs, the future is digital first—and sales reps 2nd

While many people are suffering from Zoom fatigue and looking forward to in-person meetups, that isn’t really the case when it comes to HCPs and pharma reps. As with...

13 December 2021 Regional News Amgen | Bristol Myers Squibb

Continue Reading →